FDA s Lesko Says Pharmacogenomics Guidance Paper Due Mid-Year | GenomeWeb

At A Glance

Name: Lawrence Lesko

Position: Chair of the FDA’s Pharmacogenomics Working Group; Director of the Office of Clinical Pharmacology and Biopharmaceuticals, CDER, FDA, since 1995

Background: After serving as an associate professor of pharmaceutics at the University of Maryland at Baltimore between 1981 and 1988, Lesko was named vice president of PharmaKinetics Labs, a position he held for three years.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.